Bevacizumab (216974-75-3) ≥98%
Koffínsýra fenýlenster (CAPE) ≥98%
Cortexolone 17a-própíónat ≥98%
Dolastatín 10 (110417-88-4) ≥98%
Fosaprepitant dimeglumine (EMEND) ≥98%
MMAD (Demethyldolastatin 10) ≥98%
MMAF (hýdróklóríð) (1415246-68-2) ≥98%
Monomethyl auristatin E (MMAE) ≥98%
N-Boc-dólapróín (120205-50-7) ≥98%
Pyridoxal-5-fosfat Mónóhýdrat ≥98%
3-Methoxy-13-ethyl-gona-2,5 (10)-diene-17-ol ≥98%
N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide ≥98%